Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016
Open accessThe DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Stimulants are considered the first-line treatment for Attention Deficit Hyperactivity Disorder (ADHD) in the US and they are used in other indications. Stimulants are also diverted for non-medical purposes. Ethnic and regional differences in ADHD diagnosis and in stimulant use have been identified in earlier research. The objectives of this report were to examine the pharmacoepidemiological pattern of these controlled substances over the past decade and to conduct a regional analysis. METHODS: Data (drug weights) reported to the US Drug Enforcement Administration's Automation of Reports and Consolidated Orders System for four stimulants (amphetamine, methylphenidate, lisdexamfetamine, and methamphetamine) were obtained from 2006 to 2016 for Unites States/Territories. Correlations between state level use (mg/person) and Hispanic population were completed. RESULTS: Amphetamine use increased 2.5 fold from 2006 to 2016 (7.9 to 20.0 tons). Methylphenidate use, at 16.5 tons in 2006, peaked in 2012 (19.4 tons) and subsequently showed a modest decline (18.6 tons in 2016). The consumption per municipality significantly increased 7.6% for amphetamine and 5.5% for lisdexamfetamine but decreased 2.7% for methylphenidate (all p < .0005) from 2015 to 2016. Pronounced regional differences were also observed. Lisdexamfetamine use in 2016 was over thirty-fold higher in the Southern US (43.8 mg/person) versus the Territories (1.4 mg/person). Amphetamine use was about one-third lower in the West (48.1 mg/person) relative to the Northeastern (75.4 mg/person, p < .05) or the Midwestern (69.9 mg/person, p ≤ .005) states. States with larger Hispanic populations had significantly lower methylphenidate (r(49) = -0.63), lisdexamfetamine (B, r(49) = -0.49), and amphetamine (r(49) = -0.43) use. CONCLUSIONS: Total stimulant usage doubled in the last decade. There were dynamic changes but also regional disparities in the use of stimulant medications. Future research is needed to better understand the reasons for the sizable regional and ethnic variations in use of these controlled substances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Diagnostic and Statistical Manual of Mental Disorders, 5th ed.
Carter, M. J. (2014) · Therapeutic Recreation Journal · Cited by 15,169
Johnston, L. D., O'Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2009) · PsycEXTRA Dataset · doi:10.1037/e560352009-001 · Cited by 6,921
Kessler, R. C., Adler, L., Barkley, R., Biederman, J., Conners, C. K., Demler, O., Faraone, S. V., Greenhill, L. L., Howes, M. J., Secnik, K., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.4.716 · Cited by 3,886
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Castellanos, F. X. (2002) · JAMA · doi:10.1001/jama.288.14.1740 · Cited by 1,646
Health Care Spending in the United States and Other High-Income Countries
Papanicolas, I., Woskie, L. R., & Jha, A. K. (2018) · JAMA · doi:10.1001/jama.2018.1150 · Cited by 1,626
Prevalence of Obesity and Severe Obesity in US Children, 1999–2016
Skinner, A. C., Ravanbakht, S. N., Skelton, J. A., Perrin, E. M., & Armstrong, S. C. (2018) · Pediatrics · doi:10.1542/peds.2017-3459 · Cited by 1,412
Visser, S. N., Danielson, M. L., Bitsko, R. H., Holbrook, J. R., Kogan, M. D., Ghandour, R. M., Perou, R., & Blumberg, S. J. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.001 · Cited by 1,263
Danielson, M. L., Bitsko, R. H., Ghandour, R. M., Holbrook, J. R., Kogan, M. D., & Blumberg, S. J. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2017.1417860 · Cited by 1,181
Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016.
Seth, P., Scholl, L., Rudd, R. A., & Bacon, S. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6712a1 · Cited by 821
(2010) · PsycEXTRA Dataset · doi:10.1037/e664852010-002 · Cited by 456
Association of maternal hypertension and chorioamnionitis with preterm outcomes.
Gagliardi, L., Rusconi, F., Bellù, R., r, Z., Laforgia, N., & in Italian Neonatal Network (2014) · CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) · doi:10.1542/peds · Cited by 424
Han, D. D., & Gu, H. H. (2006) · BMC Pharmacology · doi:10.1186/1471-2210-6-6 · Cited by 419
Trends of Outpatient Prescription Drug Utilization in US Children, 2002–2010
Chai, G., Governale, L., McMahon, A. W., Trinidad, J. P., Staffa, J., & Murphy, D. (2012) · Pediatrics · doi:10.1542/peds.2011-2879 · Cited by 370
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
Storebø, O. J., Ramstad, E., Krogh, H. B., Nilausen, T. D., Skoog, M., Holmskov, M., Rosendal, S., Groth, C., Magnusson, F. L., Moreira-Maia, C. R., et al. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009885.pub2 · Cited by 347
Attention-deficit/hyperactivity disorder and very preterm/very low birth weight: a meta-analysis
Franz, A. P., Bolat, G. U., Bolat, H., Matijasevich, A., Santos, I. S., Silveira, R. C., Procianoy, R. S., Rohde, L. A., & Moreira-Maia, C. R. (2018) · Pediatrics · doi:10.1542/peds.2017-1645 · Cited by 317
Racial and Ethnic Disparities in ADHD Diagnosis and Treatment
Coker, T. R., Elliott, M. N., Toomey, S. L., Schwebel, D. C., Cuccaro, P., Tortolero Emery, S., Davies, S. L., Visser, S. N., & Schuster, M. A. (2016) · PEDIATRICS · doi:10.1542/peds.2016-0407 · Cited by 316
Stigma in attention deficit hyperactivity disorder
Mueller, A. K., Fuermaier, A. B. M., Koerts, J., & Tucha, L. (2012) · ADHD Attention Deficit and Hyperactivity Disorders · doi:10.1007/s12402-012-0085-3 · Cited by 306
Are Stimulants Overprescribed? Treatment of ADHD in Four U.S. Communities
JENSEN, P. S., KETTLE, L., ROPER, M. T., SLOAN, M. T., DULCAN, M. K., HOVEN, C., BIRD, H. R., BAUERMEISTER, J. J., & PAYNE, J. D. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199907000-00008 · Cited by 304
Fusar-Poli, P., Rubia, K., Rossi, G., Sartori, G., & Balottin, U. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11060940 · Cited by 260
Associations Between Adverse Childhood Experiences and ADHD Diagnosis and Severity
Brown, N. M., Brown, S. N., Briggs, R. D., Germán, M., Belamarich, P. F., & Oyeku, S. O. (2017) · Academic Pediatrics · doi:10.1016/j.acap.2016.08.013 · Cited by 254
Wang, T., Liu, K., Li, Z., Xu, Y., Liu, Y., Shi, W., & Chen, L. (2017) · BMC Psychiatry · doi:10.1186/s12888-016-1187-9 · Cited by 240
Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets
Aldridge, J., & Décary-Hétu, D. (2016) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2016.04.020 · Cited by 237
Hinshaw, S. P. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-050817-084917 · Cited by 236
Early Autism Detection: Are We Ready for Routine Screening?
Al-Qabandi, M., Gorter, J. W., & Rosenbaum, P. (2011) · Pediatrics · doi:10.1542/peds.2010-1881 · Cited by 227
The impending globalization of ADHD: Notes on the expansion and growth of a medicalized disorder
Conrad, P., & Bergey, M. R. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.10.019 · Cited by 214
Cosgrove, L., & Krimsky, S. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001190 · Cited by 209
Overdiagnosis: How Our Compulsion for Diagnosis May Be Harming Children
Coon, E. R., Quinonez, R. A., Moyer, V. A., & Schroeder, A. R. (2014) · Pediatrics · doi:10.1542/peds.2014-1778 · Cited by 205
Attention deficit hyperactivity disorder: diagnosis and management
Chaplin, S. (2018) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.511 · Cited by 197
The Global Market For ADHD Medications
Scheffler, R. M., Hinshaw, S. P., Modrek, S., & Levine, P. (2007) · Health Affairs · doi:10.1377/hlthaff.26.2.450 · Cited by 196
Identifying students faking ADHD: Preliminary findings and strategies for detection
HARRISON, A., EDWARDS, M., & PARKER, K. (2007) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2007.03.008 · Cited by 185
Detection of feigned ADHD in college students.
Sollman, M. J., Ranseen, J. D., & Berry, D. T. R. (2010) · Psychological Assessment · doi:10.1037/a0018857 · Cited by 184
Regulation of the dopamine transporter: Aspects relevant to psychostimulant drugs of abuse
Schmitt, K. C., & Reith, M. E. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05148.x · Cited by 180
Russell, G., Ford, T., Rosenberg, R., & Kelly, S. (2014) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12170 · Cited by 180
Sleep and student performance at school
Taras, H., & Potts-Datema, W. (2005) · Journal of School Health · doi:10.1111/j.1746-1561.2005.tb06685.x · Cited by 178
Trends in ADHD medication use in children and adolescents in five western countries, 2005–2012
Bachmann, C., Wijlaars, L. P. M. M., Kalverdijk, L. J., Burcu, M., Glaeske, G., Schuiling‐Veninga, C. C. M., Hoffmann, F., Aagaard, L., & ZITO, J. M. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.03.002 · Cited by 171
Scheffler, R. M., Brown, T. T., Fulton, B. D., Hinshaw, S. P., Levine, P., & Stone, S. (2009) · Pediatrics · doi:10.1542/peds.2008-1597 · Cited by 160
Spending on children’s personal health care in the United States, 1996-2013.
Bui, A. L., Dieleman, J. L., Hamavid, H., Birger, M., Chapin, A., Duber, H. C., Horst, C., Reynolds, A., Squires, E., Chung, P. J., et al. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2016.4086 · Cited by 151
Moll, G. H., Hause, S., Rüther, E., Rothenberger, A., & Huether, G. (2001) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454601750143366 · Cited by 147
ADHD in Germany: Trends in Diagnosis and Pharmacotherapy
Bachmann, C., Philipsen, A., & Hoffmann, F. (2017) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2017.0141 · Cited by 144
Heritability of attention‐deficit hyperactivity disorder in adults
Brikell, I., Kuja‐Halkola, R., & Larsson, H. (2015) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32335 · Cited by 143
Challenges in defining the rates of ADHD diagnosis and treatment: trends over the last decade
Davidovitch, M., Koren, G., Fund, N., Shrem, M., & Porath, A. (2017) · BMC Pediatrics · doi:10.1186/s12887-017-0971-0 · Cited by 131
Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
Punja, S., Shamseer, L., Hartling, L., Urichuk, L., Vandermeer, B., Nikles, J., & Vohra, S. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009996.pub2 · Cited by 122
Dalsgaard, S., Kvist, A. P., Leckman, J. F., Nielsen, H. S., & Simonsen, M. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0020 · Cited by 121
Brault, M.-C., & Lacourse, É. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700206 · Cited by 111
A Warning Sign on the Road to DSM-V: Beware of Its Unintended Consequences
FRANCES, A. J. (2009) · Cited by 99
Trends in Medical Use of Opioids in the U.S., 2006–2016
Piper, B. J., Shah, D. T., Simoyan, O. M., McCall, K. L., & Nichols, S. D. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.01.034 · Cited by 96
Self-citationIs ADHD a valid diagnosis in adults? Yes
Asherson, P., Adamou, M., Bolea, B., Muller, U., Morua, S. D., Pitts, M., Thome, J., & Young, S. (2010) · BMJ · doi:10.1136/bmj.c549 · Cited by 89
Is Adult Attention-Deficit Hyperactivity Disorder Being Overdiagnosed?
Paris, J., Bhat, V., & Thombs, B. (2015) · The Canadian Journal of Psychiatry · doi:10.1177/070674371506000705 · Cited by 81
Adults Faking ADHD: You Must Be Kidding!
Harrison, A. G. (2006) · The ADHD Report · doi:10.1521/adhd.2006.14.4.1 · Cited by 80
DSM-5 Further Inflates Attention Deficit Hyperactivity Disorder
Batstra, L., & Frances, A. (2012) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e318257c4b6 · Cited by 79
Recent Trends in Stimulant Usage
Safer, D. J. (2016) · Journal of Attention Disorders · doi:10.1177/1087054715605915 · Cited by 78
Using Symptom Validity Tests to Detect Malingered ADHD in College Students
Jasinski, L. J., Harp, J. P., Berry, D. T. R., Shandera-Ochsner, A. L., Mason, L. H., & Ranseen, J. D. (2011) · The Clinical Neuropsychologist · doi:10.1080/13854046.2011.630024 · Cited by 78
Visser, S. N., Danielson, M. L., Wolraich, M. L., Fox, M. H., Grosse, S. D., Valle, L. A., Holbrook, J. R., Claussen, A. H., & Peacock, G. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6517e1 · Cited by 77
Yolton, K. A., Cornelius, M. D., Ornoy, A., McGough, J. J., Makris, S. L., & Schantz, S. L. (2014) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2014.05.003 · Cited by 66
Is ADHD a valid diagnosis in adults? No
Moncrieff, J., & Timimi, S. (2010) · BMJ · doi:10.1136/bmj.c547 · Cited by 64
Piper, B. J., Acevedo, S. F., Kolchugina, G., Butler, R. W., Corbett, S. M., Honeycutt, E. B., Craytor, M. J., & Raber, J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.02.013 · Cited by 56
Self-citationAn Investigation of Reported Symptoms of ADHD in a University Population
Harrison, A. G. (2004) · The ADHD Report · doi:10.1521/adhd.12.6.8.55256 · Cited by 56
Anderson, K. N., Ailes, E. C., Danielson, M., Lind, J. N., Farr, S. L., Broussard, C. S., & Tinker, S. C. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6702a3 · Cited by 54
Academy of Pediatric Education and Leadership: Preparing Leaders for Educational Innovation
Hobson, W. L., Carey, J. C., & Bale, J. F. (2011) · Pediatrics · doi:10.1542/peds.2011-0662 · Cited by 51
Fulton, B. D., Scheffler, R. M., & Hinshaw, S. P. (2015) · Psychiatric Services · doi:10.1176/appi.ps.201400145 · Cited by 49
Trends in Stimulant Medication Use in Commercially Insured Youths and Adults, 2010-2014
Burcu, M., Zito, J. M., Metcalfe, L., Underwood, H., & Safer, D. J. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.1182 · Cited by 49
School accountability laws and the consumption of psychostimulants
Bokhari, F. A. S., & Schneider, H. M. (2011) · Journal of Health Economics · doi:10.1016/j.jhealeco.2011.01.007 · Cited by 46
Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers
Kaland, M. E., & Klein-Schwartz, W. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1027903 · Cited by 39
Estcourt, L. J., Fortin, P. M., Hopewell, S., & Trivella, M. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012082 · Cited by 39
Somkuwar, S. S., Darna, M., Kantak, K. M., & Dwoskin, L. P. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.04.013 · Cited by 37
Executive Function Profile in the Offspring of Women That Smoked During Pregnancy
Piper, B. J., & Corbett, S. M. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr181 · Cited by 37
Self-citationOff-label Prescribing Trends for ADHD Medications in Very Young Children
Panther, S. G., Knotts, A. M., Odom‐Maryon, T., Daratha, K., Woo, T. M., & Klein, T. (2017) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-22.6.423 · Cited by 34
Bird, H. R., Shrout, P. E., Duarte, C. S., Shen, S., Bauermeister, J. J., & Canino, G. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e318179963c · Cited by 33
Visser, S. N., Blumberg, S. J., Danielson, M. L., Bitsko, R. H., & Kogan, M. D. (2013) · Preventing Chronic Disease · doi:10.5888/pcd9.120073 · Cited by 32
Winterstein, A. G., Soria-Saucedo, R., Gerhard, T., Correll, C. U., & Olfson, M. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.16m10884 · Cited by 32
Ji, X., Druss, B. G., Lally, C. A., & Cummings, J. R. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600469 · Cited by 32
Smith, S. T., Cox, J. M., Mowle, E. N., & Edens, J. F. (2017) · Psychological Assessment · doi:10.1037/pas0000435 · Cited by 27
Piper, B. J., Desrosiers, C. E., Lipovsky, J. W., Rodney, M. A., Baker, R. P., McCall, K. L., Nichols, S. D., & Martin, S. L. (2016) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2016.77.556 · Cited by 26
Self-citationNyarko, K. A., Grosse, S. D., Danielson, M. L., Holbrook, J. R., Visser, S. N., & Shapira, S. K. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0196 · Cited by 23
Boesen, K., Saiz, L. C., Erviti, J., Storebø, O. J., Gluud, C. N., Gøtzsche, P. C., & Jørgensen, K. J. (2017) · BMJ Evidence-Based Medicine · doi:10.1136/ebmed-2017-110716 · Cited by 23
Hoagwood, K., Kelleher, K. J., Zima, B. T., Perrin, J. M., Bilder, S. M., & Crystal, S. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1423 · Cited by 21
Continuous Performance Testing in the Differential Diagnosis of ADHD
Homack, S. R., & Reynolds, C. R. (2005) · The ADHD Report · doi:10.1521/adhd.2005.13.5.5 · Cited by 20
León, K. S., & Martínez, D. E. (2016) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2016.1260187 · Cited by 18
Lang, H., Scheffler, R. M., & Hu, T.-W. (2010) · Health Policy · doi:10.1016/j.healthpol.2010.03.005 · Cited by 14
Trade Agreements and Direct-to-Consumer Advertising of Pharmaceuticals
Gleeson, D., & Menkes, D. B. (2017) · International Journal of Health Policy and Management · doi:10.15171/ijhpm.2017.124 · Cited by 11
Hulkower, R. L., Kelley, M., Cloud, L. K., & Visser, S. N. (2017) · Public Health Reports · doi:10.1177/0033354917735548 · Cited by 11
Strawn, M. N. (2003) · PubMed · Cited by 5
Medication Treatment of ADHD in Latino/Hispanic Children
Bauermeister, J. J. (2005) · The ADHD Report · doi:10.1521/adhd.2005.13.3.5 · Cited by 4
Research works printed but not linked: 1
- G Jachimowicz, 2004, Comparison of ease of falsification of Attention Deficit Hyperactivity Disorder diagnosis using standard behavioral rating scales, Cognitive Science Online, 2, 6
Cited by
ADHD: Current Concepts and Treatments in Children and Adolescents
Drechsler, R., Brem, S., Brandeis, D., Grünblatt, E., Berger, G., & Walitza, S. (2020) · Neuropediatrics · doi:10.1055/s-0040-1701658 · Cited by 415
Neurobiology, Clinical Presentation, and Treatment of Methamphetamine Use Disorder: A Review
Paulus, M. P., & Stewart, J. L. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.0246 · Cited by 310
Garcia-Romeu, A., Davis, A. K., Erowid, E., Erowid, F., Griffiths, R. R., & Johnson, M. W. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00955 · Cited by 157
Danielson, M. L., Holbrook, J. R., Bitsko, R. H., Newsome, K., Charania, S., McCord, R. F., Kogan, M. D., & Blumberg, S. J. (2022) · Journal of Attention Disorders · doi:10.1177/10870547221099961 · Cited by 88
Neurodevelopmental Disorders: Past, Present, and Future
Cainelli, E., & Bisiacchi, P. S. (2022) · Children · doi:10.3390/children10010031 · Cited by 87
Metadata
- Authors
- Piper, B. J., Ogden, C. L., Simoyan, O. M., Chung, D. Y., Caggiano, J. F., Nichols, S. D., & McCall, K. L.
- Affiliations
- Geisinger College of Health Sciences (US)
- Tufts University (US)
- University of New England (US)
- Corresponding author
- Piper, Brian J.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2018-11-28
- Volume
- 13
- Issue
- 11
- Pages
- e0206100
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6261411
- OpenAlex
- W2903069810
- Cited by
- 170
- References
- 85
- Citations by year
- 2026: 8 · 2025: 23 · 2024: 15 · 2023: 27 · 2022: 42 · 2021: 24 · 2020: 23 · 2019: 6
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute of Environmental Health Sciences (T32 ES007060-31A1)
- Husson University School of Pharmacy (2013-01)
- Fahs-Beck Fund for Research and Experimentation (2017-01)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- stimulant medication, amphetamine, methylphenidate, lisdexamfetamine, methamphetamine, ADHD medication, drug diversion, regional disparities, Hispanic population, pharmacoepidemiology, controlled substances, drug use trends, Southern United States, northeastern United States, ethnic disparities
- MeSH terms
- Central Nervous System Stimulants, Geography, Humans, United States, United States Food and Drug Administration, Prescriptions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.